LPD lipase, a crucial enzyme in the metabolic pathway, plays a significant role in the hydrolysis of fats within the body. Its expression and activity are essential for the maintenance of normal lipid homeostasis, making the understanding of its regulation a topic of interest in biochemical research. The expression of LPD lipase can be influenced by a variety of dietary and endogenous compounds that serve as activators, enhancing the enzyme's transcription and activity levels. These activators can be naturally occurring within the body or found in dietary sources and are primarily involved in the intricate network of lipid metabolism. For instance, cyclic AMP (cAMP) is a well-known intracellular messenger that can upregulate LPD lipase expression through the activation of protein kinase A, a signaling pathway that phosphorylates and activates transcription factors. This cascade effect leads to the enhanced transcription of the LPD lipase gene, showcasing the complexity of cellular regulation mechanisms.
On the dietary front, polyunsaturated fatty acids (PUFAs) are known to play a role in membrane fluidity and cellular signaling, which can indirectly lead to the induction of LPD lipase expression. The presence of specific PUFAs in the cellular environment may trigger signaling pathways that culminate in the transcriptional activation of the LPD lipase gene. Moreover, compounds like bezafibrate and fenofibrate, classified as fibrates, are recognized for their ability to act as PPAR agonists. As a result, they can stimulate the transcription of genes involved in fatty acid oxidation, potentially increasing the expression of LPD lipase. Other dietary components such as omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are also implicated in the upregulation of LPD lipase expression. These fatty acids may enhance the activity of lipid-sensing receptors, thereby promoting a physiological response that includes the upregulation of LPD lipase to maintain lipid equilibrium within the body. The role of these activators underscores the intricate balance of metabolic processes and the adaptability of the enzyme's expression in response to internal and external cues.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bezafibrate | 41859-67-0 | sc-204650B sc-204650 sc-204650A sc-204650C | 500 mg 1 g 5 g 10 g | $30.00 $45.00 $120.00 $200.00 | 5 | |
Bezafibrate may upregulate LPD lipase expression by acting as a peroxisome proliferator-activated receptor (PPAR) agonist, leading to increased transcription of genes involved in fatty acid oxidation. | ||||||
Fenofibrate | 49562-28-9 | sc-204751 | 5 g | $40.00 | 9 | |
Fenofibrate could stimulate LPD lipase gene transcription through activation of PPARα, promoting the catabolism of triglycerides and enhancing fatty acid oxidation. | ||||||
Eicosa-5Z,8Z,11Z,14Z,17Z-pentaenoic Acid (20:5, n-3) | 10417-94-4 | sc-200766 sc-200766A | 100 mg 1 g | $102.00 $423.00 | ||
Eicosapentaenoic acid (EPA) may induce LPD lipase expression by interacting with receptors involved in lipid sensing, which could lead to an upsurge in enzymatic activity for maintaining lipid balance. | ||||||
Gemfibrozil | 25812-30-0 | sc-204764 sc-204764A | 5 g 25 g | $65.00 $262.00 | 2 | |
Gemfibrozil may prompt LPD lipase gene expression by activating liver PPARα, leading to an increased breakdown of fatty acids and a reduction in serum triglyceride levels. | ||||||
Nicotinic Acid | 59-67-6 | sc-205768 sc-205768A | 250 g 500 g | $61.00 $122.00 | 1 | |
Niacin can induce LPD lipase expression through its role as a ligand for the niacin receptor, which is involved in the biochemical pathway of lipolysis and free fatty acid release. | ||||||
Clofibrate | 637-07-0 | sc-200721 | 1 g | $32.00 | ||
Clofibrate could elevate LPD lipase expression by acting as an agonist to PPARs, playing a key role in the transcriptional activation of genes involved in lipid metabolism. | ||||||
Pioglitazone | 111025-46-8 | sc-202289 sc-202289A | 1 mg 5 mg | $54.00 $123.00 | 13 | |
Pioglitazone may upregulate LPD lipase expression via PPARγ activation, crucial in the transcriptional control of genes for lipid storage and glucose metabolism. | ||||||
Rosiglitazone | 122320-73-4 | sc-202795 sc-202795A sc-202795C sc-202795D sc-202795B | 25 mg 100 mg 500 mg 1 g 5 g | $118.00 $320.00 $622.00 $928.00 $1234.00 | 38 | |
Rosiglitazone could increase LPD lipase expression by binding to PPARγ, stimulating the transcriptional activity of genes essential for lipid metabolism. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Retinoic acid can stimulate LPD lipase expression by interacting with retinoic acid receptors, which may lead to increased transcription of genes involved in lipid processing. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $114.00 $175.00 $260.00 $362.00 $617.00 $1127.00 | ||
Adenosine 3',5'-cyclic monophosphate can upregulate LPD lipase through the activation of protein kinase A (PKA), which phosphorylates transcription factors that enhance the gene's expression. | ||||||